Robert M. Straubinger
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 11
- Lipid Membrane Structure and Behavior 9
- Oncology 44
- Pancreatic and Hepatic Oncology Research 18
- Cancer Treatment and Pharmacology 16
- Co-authors
- Demetrios Papahadjopoulos (11 shared papers)Sathyamangalam V. Balasubramanian (11 shared papers)Amarnath Sharma (6 shared papers)Keelung Hong (4 shared papers)Donald E. Mager (16 shared papers)Daniel S. Friend (3 shared papers)Nejat Düzgüneş (2 shared papers)Jun Qu (22 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (14 papers)Pharmaceutical Research (11 papers)Cancer Chemotherapy and Pharmacology (4 papers)Cancer Research (4 papers)Biochemistry (4 papers)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Robert M. Straubinger
127 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 140
- Biomaterials 1.5k
- Pharmaceutical Science 369
- Molecular Biology 2.6k
- Oncology 910
- Microbiology 198
Countries citing papers authored by Robert M. Straubinger
This map shows the geographic impact of Robert M. Straubinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Straubinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Straubinger more than expected).
Fields of papers citing papers by Robert M. Straubinger
This network shows the impact of papers produced by Robert M. Straubinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Straubinger. The network helps show where Robert M. Straubinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert M. Straubinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 346 | |
| 2 | 1985 | 196 | |
| 3 | 1994 | 183 | |
| 4 | 1985 | 177 | |
| 5 | 1998 | 175 | |
| 6 | 2019 | 149 | |
| 7 | 1995 | 148 | |
| 8 | 1981 | 143 | |
| 9 | 1990 | 119 | |
| 10 | 1995 | 112 | |
| 11 | 2001 | 111 | |
| 12 | 2009 | 109 | |
| 13 | 1996 | 105 | |
| 14 | 1994 | 104 | |
| 15 | 1989 | 100 | |
| 16 | 2001 | 97 | |
| 17 | 2003 | 89 | |
| 18 | 1996 | 78 | |
| 19 | 2014 | 74 | |
| 20 | 1988 | 66 |
About Robert M. Straubinger
Robert M. Straubinger is a scholar working on Molecular Biology, Oncology, Biomaterials, Biomedical Engineering and Spectroscopy, having authored 127 papers that have together received 5.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (25 papers), Pancreatic and Hepatic Oncology Research (18 papers), Cancer Treatment and Pharmacology (16 papers), RNA Interference and Gene Delivery (11 papers), Mass Spectrometry Techniques and Applications (9 papers), Lipid Membrane Structure and Behavior (9 papers), Nanoplatforms for cancer theranostics (9 papers) and Microtubule and mitosis dynamics (7 papers). The work is most often cited by research in Biomaterials (1.5k citations), Pharmaceutical Science (369 citations), Molecular Biology (2.6k citations), Oncology (910 citations) and Microbiology (198 citations). Robert M. Straubinger has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Demetrios Papahadjopoulos, Sathyamangalam V. Balasubramanian, Amarnath Sharma, Keelung Hong, Donald E. Mager, Daniel S. Friend, Nejat Düzgüneş, Jun Qu, Yu‐Kyoung Oh and William J. Jusko. Their work appears in journals such as Journal of Pharmaceutical Sciences, Pharmaceutical Research, Cancer Chemotherapy and Pharmacology, Cancer Research and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.